Therapeutic approaches of nephrotic syndrome in children at the beginning of the XXI century;Tratamiento del síndrome nefrótico del niño en los inicios del siglo XXI

Nefrologia

Volumn 23, Issue 4, 2003, Pages 287-290

  Simon J ^a   Zamora, I ^a  

^a HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID; PREDNISONE; ANTIINFLAMMATORY AGENT;

CLINICAL FEATURE; EDITORIAL; FOCAL GLOMERULONEPHRITIS; HEALTH CARE POLICY; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; CHILD; CLINICAL TRIAL; DRUG ADMINISTRATION;

ANTI-INFLAMMATORY AGENTS; CHILD; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEPHROTIC SYNDROME; PREDNISONE;

EID: 0642369540     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. International Study of Kidney Disease in Children: Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13: 159-165, 1978.
2. Haas M, Spargo BH, Coventry S: Increasing incidencia of focal-segmental glomeruloesclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995.
3. Srivastara T, Simon SD, Alen US: High: incidencia of focal segmental glomerulosclerosis in nephrotic syndrome of childhod. Pediatr Nephrol 13: 13-18, 1999.
4. Gulati S, Shauma AP, Shauma RK, Gupta FA: Changing Trends of histopathology in Clildhood Nephrotic Syndrome. Am J Kidney Dis 34: 646-650, 1990.
5. Vehaskari JM: Treatment practics of FSGS among North American pediatric Nephrologists. Pediatr Nephrol 13: 301-303, 1999.
6. Tarshih P, Tobin JN, Bernstein J, Edelman CM Jr. Cyclophosphamide does no benefict patients with focal segmental glomerulosclerosis. Pediatr Nephrol 10: 590-593, 1996.
7. Collaborative Study group of Sandimmun in Nephrotic Syndrome. Clin Nephrol 35: S48-S60, 1991.
8. McCauley J, Shapiro R, Ellis D, Igdal H, Tzakis A, Staurzl TE: Pilot trial of FK506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 8: 1286-1290, 1993.
9. Mendoza SA, Reznick VA, William R, Griswold WR, Krensky AM, Yousin PD, Tune BM: Treatment of steroid resistant focal segmental glomeruloclerosis with pulse methylprednisolona and alkylating agents. Pediatr Nephrol 4: 303-307, 1990.